Laboratory of Tumour Clinical and Genetic Research
Summary of scientific activities on the RSU Research Portal
The Institute of Hereditary Cancer was founded in 2001 by Rīga Stradiņš University (RSU) in collaboration with Prof. Jan Lubinski (Pomeranian Medical University, Szczecin, Poland). Its first director was Prof. Jānis Gardovskis. As its activities and research areas expanded, the institute was renamed the Institute of Oncology in 2012. After the consolidation of RSU in 2024, the Institute of Oncology and Molecular Genetics was established and the legacy of the Institute of Oncology was taken over by the Laboratory of Tumour Clinical and Genetic Research of the newly established institute.
The Laboratory of Tumour Clinical and Genetic Research is involved in national and international grants, cooperation programmes, research projects and clinical trials, and provides support for students, residents, and doctoral students in their research work.
Employees
Laboratory of Tumour Clinical and Genetic Research
Related news
Doctoral position (DC8) open at RSU within the BioTransform MSCA projectResearch, For PhD Students
Institute of Public Health study confirms importance and cost-effectiveness of vaccinationResearch, Public Health
Rīga Stradiņš University joins major Nordic-Baltic collaboration project on research data managementResearch, Research data management
Research Project Launched on Demographic Change, Migration, and Re-emigration under Conditions of Geopolitical UncertaintyResearch
RSU Joins an International Study on the Resilience of Science and Society in Conditions of War and Global CrisesResearch, International Cooperation










